Cleo Diagnostics Ltd (ASX:COV)

Cleo Diagnostics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Apr 25, 2025	Jun 30, 2024	Jun 30, 2023
Market Capitalization	57	44	-
Enterprise Value	49	34	-
Last Close Price	0.44	0.34	-
PS Ratio	268.20	207.25	-
PB Ratio	7.60	4.65	-
P/TBV Ratio	8.01	4.86	-
EV/Sales Ratio	233.52	159.30	-
Debt / Equity Ratio	-	-	-1.70
Asset Turnover	0.02	0.04	-
Quick Ratio	16.51	19.40	0.13
Current Ratio	16.70	19.41	0.29
Return on Equity (ROE)	-34.46%	-88.99%	-
Return on Assets (ROA)	-21.46%	-41.55%	-
Return on Capital (ROIC)	-22.23%	-45.30%	-
Earnings Yield	-5.48%	-8.60%	-
FCF Yield	-4.95%	-4.65%	-
Buyback Yield / Dilution	-25.28%	-346.76%	-

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.